Vitality Watch

Dossier pubmed review 30-sep-2026
Narrative review or expert overview without new data

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.

Key claim: Lifelong Epstein-Barr virus persistence acts as a functional stress test of ageing immune surveillance, revealing and amplifying deficits in viral containment, tissue immune ecology, and inflammatory regulation that permit reactivation, hyperinflammation, lymphoproliferation, or malignancy.

Abstract

Epstein-Barr virus (EBV) infects most humans and persists lifelong within a dynamic equilibrium maintained by B-cell latency, cytotoxic T-cell control, NK-cell surveillance and humoral immunity. Ageing can remodel this equilibrium through thymic involution, contraction of the naive T-cell pool, accumulation of late-differentiated or exhaustion-like T-cell states, altered NK-cell function, B-cell dysfunction and chronic low-grade inflammation. Although cytomegalovirus has dominated discussions of persistent viral infection and immunosenescence, EBV offers a complementary model because it combines lifelong latency, intermittent reactivation, B-cell tropism, immune evasion and clinically diverse lymphoid, epithelial and hyperinflammatory disease contexts. This review conceptualizes EBV persistence as a functional stress test of ageing immune surveillance. Instead of assigning EBV a binary role as either a driver or passenger of immunosenescence, we argue that EBV may reveal and amplify deficits in viral containment, tissue immune ecology and inflammatory regulation. We integrate evidence from EBV-specific immune control, T-cell and NK-cell ageing, B-cell remodelling, inflammaging and EBV-associated diseases including IM, CAEBV, ENKTL, EBV-HLH, EBVMCU, EBV-positive DLBCL, PTLD, NPC and EBV-associated gastric cancer. These entities are organized as parallel immune-control states rather than as a chronological disease sequence: CAEBV and ENKTL illustrate T/NK-lineage containment failure, EBV-HLH links impaired cytotoxic reserve with inflammatory escalation, B-cell lymphoproliferative diseases illustrate surveillance loss, and epithelial cancers illustrate tissue-specific latency and local immune editing. A lifespan perspective on EBV may therefore clarify why some immune systems maintain resilient latency, whereas others lose EBV-control reserve and become permissive to reactivation, hyperinflammation, lymphoproliferation or malignancy.

Why this matters

This review consolidates a disease-anchored way to read immune aging: instead of relying on cytokine panels or T-cell subset counts in isolation, it uses the behavior of a near-universal latent virus as a lifelong functional probe of whether surveillance still works. It bridges the immunosenescence and inflammaging pages with a concrete pathogen axis and names where the biology becomes clinical — mononucleosis severity in older first-exposure hosts, chronic active EBV disease, post-transplant lymphoproliferative disease, and EBV-associated malignancy. No new primary data; the contribution is framing that converts dispersed EBV-disease literature into a geroscience-usable control model.

Source

Link

Briefing card

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.
Stage: review · pubmed · 30-sep-2026

If you carry latent EBV (as most adults do), this review frames age-related slips in your immune surveillance — not the virus itself — as what determines whether EBV stays silent or drives reactivation, hyperinflammation, or lymphoproliferation later in life.

Lifelong Epstein-Barr virus persistence acts as a functional stress test of ageing immune surveillance, revealing and amplifying deficits in viral containment, tissue immune ecology, and inflammatory regulation that permit reactivation, hyperinflammation, lymphoproliferation, or malignancy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103387

build build 880 · 2bcef25 · 2026-11-18